baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UniCredit Knock-Out NEXI/ DE000HD3B5F7 /

6/14/2024 9:14:56 PM	Chg.-0.190	Bid10:00:42 PM	Ask10:00:42 PM	Underlying	Strike price	Expiration date	Option type
0.450EUR	-29.69%	- Bid Size: -	- Ask Size: -	NEXI	5.3184 -	12/31/2078	Call

GlobeNewswire 6/12 Worthington Enterprises Schedules Fourth Quarter 2024 Earnings Call for June 26

GlobeNewswire 6/3 Worthington Enterprises Completes Acquisition of Hexagon Ragasco

GlobeNewswire 10/24/2023 NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes

GlobeNewswire 10/19/2023 NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting

GlobeNewswire 10/18/2023 NexImmune Announces 1-for-25 Reverse Stock Split

GlobeNewswire 9/29/2023 Calian Launches Digital Health Portfolio of Products and Services

GlobeNewswire 9/28/2023 Northland Power Announces Financial Close of the 1.0 GW Hai Long Offshore Wind Project in Taiwan Fin...

GlobeNewswire 8/31/2023 NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development ...

GlobeNewswire 3/17/2022 NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Valida...

GlobeNewswire 3/14/2022 NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center

GlobeNewswire 3/10/2022 NexImmune to Present at the Barclays 2022 Global Healthcare Conference

GlobeNewswire 3/9/2022 NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates

GlobeNewswire 2/17/2022 NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors

GlobeNewswire 1/5/2022 NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board

GlobeNewswire 12/12/2021 NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma

GlobeNewswire 11/12/2021 NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates

GlobeNewswire 11/8/2021 NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November ...

GlobeNewswire 11/3/2021 NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting

GlobeNewswire 10/20/2021 Bottomline Appoints Three New Directors to Board of Directors

GlobeNewswire 9/27/2021 NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference

GlobeNewswire 9/16/2021 SBM Offshore completes US$1.6 billion financing of Sepetiba

GlobeNewswire 9/10/2021 NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

GlobeNewswire 8/18/2021 Aite-Novarica Group Announces Winners of the 2021 Digital Wallet Innovation Awards

GlobeNewswire 8/9/2021 NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates

GlobeNewswire 8/9/2021 NexImmune to Explore the Use of AIM™ Direct Injection Technology in Type 1 Diabetes

UniCredit Knock-Out NEXI/ DE000HD3B5F7 /

If you wish to receive reply to your feedback, please provide your email address.